Ligand Pharmaceuticals Inc (LGND)
Interest Expense
$1.75M
Quarterly · Period ending: · USD
LGND Interest Expense
Latest reported$1.75Mperiod ending
Latest reported$1.75Mperiod ending
LGND Quarterly Interest Expense ($0.00 → $1.75M)
Quarterly interest expense
High-resolution chart · PNG
LGND interest expense history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Interest Expense (USD) |
|---|---|
| 1,748,000 | |
| 1,747,000 | |
| 1,785,000 | |
| 910,000 | |
| 1,153,000 | |
| 867,000 | |
| 883,000 | |
| 741,000 | |
| 1,268,000 | |
| 141,000 | |
| 131,000 | |
| 1,000 | |
| 284,000 | |
| 240,000 | |
| 240,000 | |
| 332,000 | |
| 438,000 | |
| 789,000 | |
| 4,472,000 | |
| 4,439,000 | |
| 4,883,000 | |
| 5,831,000 | |
| 6,390,000 | |
| 6,269,000 | |
| 6,213,000 | |
| 8,548,000 | |
| 8,834,000 | |
| 8,993,000 | |
| 9,012,000 | |
| 8,906,000 | |
| 20,143,000 | |
| 11,200,000 | |
| 13,454,000 | |
| 3,480,000 | |
| 2,775,000 | |
| 3,386,000 | |
| 3,341,000 | |
| 2,941,000 | |
| 3,006,000 | |
| 3,116,000 | |
| 3,051,000 | |
| 3,005,000 | |
| 2,927,000 | |
| 2,930,000 | |
| 2,969,000 | |
| 2,973,000 | |
| 2,914,000 | |
| 1,516,000 | |
| 181,000 | |
| 248,000 | |
| 322,000 | |
| 394,000 | |
| 453,000 | |
| 912,000 | |
| 845,000 | |
| 735,000 | |
| 847,000 | |
| 792,000 | |
| 715,000 | |
| 700,000 | |
| 674,000 | |
| 423,000 | |
| 19,000 | |
| 8,000 | |
| 13,000 | |
| 18,000 | |
| 13,000 | |
| 21,000 | |
| 42,000 | |
| 194,000 | |
| 0 | |
| 0 | |
| 0 | |
| 52,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |